Dyne Therapeutics (DYN) Stock Forecast & Price Target

DYN$17.16+0.15 +0.88%
BiotechnologyGrowth Stock
Compare
Market cap$3.22BEnterprise value$2.52BRevenue (TTM)$0Market position—

Score

69
Bullish
Value
55
Quality
53
Growth
100

Dyne Therapeutics, Inc. price target

DYN
Low$24.00
Average$35.20
High$50.00
Upside vs current price+105.1%

The average target of $35.20 is +105.1% versus the current DYN price of $17.16.

Dyne Therapeutics, Inc. analyst ratings

RatingAnalysts
Strong buy3
Buy12
Hold1
Sell0
Strong sell1
ConsensusBuy

17 analysts cover DYN.

Dyne Therapeutics, Inc. EPS and revenue estimates

The estimate table for the Dyne Therapeutics, Inc. keeps 2026 EPS $-3.61, 2027 EPS $-3.35, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$-3.61$995,727
2027$-3.35$53.41M

Is Dyne Therapeutics, Inc. a buy or sell?

Of the 17 analysts covering Dyne Therapeutics, Inc., 15 rate it a buy (3 strong buy and 12 buy), 1 rates it a hold, and 1 rates it a sell (0 sell and 1 strong sell).

The DYN consensus label is Buy, beside 15 buy-side ratings and 1 sell-side ratings.

The average target of $35.20 implies +105.1% versus the current price of $17.16.

the Dyne Therapeutics, Inc. closes with 15 buy-side ratings and 1 on the sell side. The headcount is Buy.

Reading the Dyne Therapeutics, Inc. forecast

Analysts are far apart on DYN. The published low is $24.00, the average is $35.20, and the high is $50.00.

From today's $17.16 print, the DYN average target is +105.1% away.

Most of the DYN coverage agrees: 15 of 17 analysts are on the buy side, 1 is at hold, and 1 is on the sell side, and the published consensus is Buy.

DYN picked up 2 downgrades in the recent window, against 0 upgrades.

Earnings estimates for DYN are rising: 2026 $-3.61, then 2027 $-3.35.

Coverage of DYN is broad at 17 analysts, and the average is a crowd rather than a single desk.

Dyne Therapeutics, Inc. forecast questions

What is the DYN price target?

The published range for DYN is $24.00 to $50.00, with an average of $35.20. That average is +105.1% versus the current price of $17.16.

Is Dyne Therapeutics, Inc. a buy or sell?

Of the 17 analysts covering Dyne Therapeutics, Inc., 15 rate it a buy, 1 rates it a hold, and 1 rates it a sell. The consensus is Buy, which for DYN is 15 on the buy side, 1 at hold, and 1 on the sell side.

What is the EPS estimate for Dyne Therapeutics, Inc.?

Analyst EPS estimates for Dyne Therapeutics, Inc.: 2026 $-3.61, 2027 $-3.35.

What is the revenue estimate for Dyne Therapeutics, Inc.?

Analyst revenue estimates for Dyne Therapeutics, Inc.: 2026 $995,727, 2027 $53.41M.

How many analysts cover DYN?

17 analysts cover DYN. Their consensus on DYN is Buy, across those 17.

DYN price $17.16 +0.15 +0.88%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener